Charles Schwab Investment Management Inc Neuronetics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Neuronetics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 106,129 shares of STIM stock, worth $302,467. This represents 0.0% of its overall portfolio holdings.
Number of Shares
106,129
Previous 15,000
607.53%
Holding current value
$302,467
Previous $55,000
572.73%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding STIM
# of Institutions
94Shares Held
18.5MCall Options Held
49.6KPut Options Held
78.8K-
Vanguard Group Inc Valley Forge, PA2.74MShares$7.82 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$4.95 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.51MShares$4.3 Million0.01% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.1MShares$3.13 Million1.17% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$2.85 Million0.14% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $77M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...